Literature DB >> 3183929

Clinical uses of collagen shields.

D E Poland1, H E Kaufman.   

Abstract

Collagen shields immersed in tobramycin solution for one minute were applied to one eye each of 60 patients who had had cataract extraction, penetrating keratoplasty, or epikeratophakia or who had nonsurgical epithelial healing problems. The shields were well tolerated; one patient had the shield removed and one patient lost the shield in the early postoperative period. The surgical patients showed more rapid healing of epithelial defects after surgery with the use of the collagen shield. Patients with acute nonsurgical epithelial problems, such as contact lens abrasions and recurrent erosion, responded to the use of the collagen shield with improved healing. Patients with chronic epithelial defects responded poorly, presumably because underlying abnormalities in Bowman's layer prevented epithelial growth in the area of the defect. No infections were noted in any of the patients. The collagen shields appear to promote enhanced healing in patients with postsurgical and acute epithelial defects and to provide adequate antibiotic prophylaxis against infection in these vulnerable eyes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183929     DOI: 10.1016/s0886-3350(88)80003-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Pharmacokinetics of ophthalmic corticosteroids.

Authors:  C N McGhee
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

Review 3.  Pharmacology and toxicology of novel drug delivery systems. Regulatory issues.

Authors:  J Weissinger
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

4.  Collagen shields and intraocular drug delivery: concentration of gentamicin in the aqueous and vitreous of a rabbit eye after lensectomy and vitrectomy.

Authors:  N Baziuk; C M Gremillion; G A Peyman; H K Cho
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

Review 5.  Pharmacokinetic considerations in the treatment of bacterial keratitis.

Authors:  M C Callegan; R J O'Callaghan; J M Hill
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

Review 6.  Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives.

Authors:  Ranjan Ku Sahoo; Nikhil Biswas; Arijit Guha; Nityananda Sahoo; Ketousetuo Kuotsu
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.